Drug Injury Lawyers

Drug Injury

Topamax, an antiepileptic and migraine medication, was analyzed in a recent European study that was designed to provide information regarding potential Topamax side effects and the potential harm that other medications could inflict on expecting mothers.

(PRWEB) - The Consumer Justice Foundation, a free online resource that provides information to consumers regarding their legal rights with regards to protecting and enforcing them against large corporations, has provided a synopsis of a large-scale statistical analysis of the antiepileptic drug Topamax and the potential Topamax side effects that could befall a child whose mother used an antiepileptic medication during the early stages of pregnancy. The Consumer Justice Foundation provides information and statistical analysis so that knowledge regarding the potential effects of Topamax in women can be brought to public attention through resources such as http://www.topamaxbirthinjury.com.

Florida Drug Injury Lawyers

Tallahassee, Florida – On Friday, May 13, Attorney General Pam Bondi will host a roundtable discussion on the effects of maternal prescription drug abuse on newborns at St. Joseph’s Women’s Hospital in Tampa, Fla. Senate President Mike Haridopolos, BayCare Health System President Stephen Mason, and St. Joseph’s Women’s Hospital Chief Operating Officer Kimberly Guy, among others, will participate. There will be a press conference following the closed-press roundtable discussion and NICU visit. Media representatives are requested to meet in the lobby.

The press conference will be held tomorrow, Friday, May 13 at 11:45 a.m. at Joseph’s Women’s Hospital, 3030 W. Dr. Martin Luther King Jr. Blvd., Tampa, Florida.

For additional information, please contact the Attorney General’s Office of Communications at 850-245-0150.

Texas Drug Injury Lawyers

The FDA recently strengthened their warning for Topamax stating that expecting mothers taking the drug are 20 times more likely to suffer a birth defect.

Austin, TX (PRWEB) - O’Hanlon, McCollom and Demerath reports: according to a 2008 scientific study published in Neurology, taking Topamax during pregnancy significantly increases the risk of cleft lip and palate birth defects. The article, “Topiramate in Pregnancy: Preliminary Experience from the UK Epilepsy and Pregnancy Register,” reviewed 203 pregnancies. Of the 178 babies born, 16 had major birth defects. Four of the babies had oral clefts – 11 times more prevalent than the normal rate.

High incidents of oral clefts from women taking Topamax were reported to the UK Epilepsy and Pregnancy Register, as well as the North American ARF Pregnancy Registry. Due to these and other serious side effects, the United States Food and Drug Administration (FDA) requested a review of Topamax birth defects on January 21, 2011. Federal regulators asked Vivius, Inc. to review potential reports of oral birth defects among children of women who took Topamax during pregnancy.

New York Drug Injury Lawyers

Bernstein Liebhard LLP, a New York law firm nationally recognized for its consumer protection and mass tort practices, is currently investigating cases of cleft lip and cleft palate and other serious side effects associated with Topamax (topiramate) use.

New York (TransWorldNews) - Topamax is a drug used to treat epilepsy and migraines. It is manufactured and sold by Ortho-McNeil Neurologics, a subsidiary of Johnson & Johnson. It first received approval by the U.S. Food and Drug Administration (“FDA”) in 2004.

In 2008, a study published in Neurology reported that there was a link between Topamax use in pregnant women and birth defects. The study, which was conducted by researchers at the Royal Group of Hospitals in Belfast, Northern Ireland, studied 203 pregnant women who were taking Topamax. Of the 178 babies born, 16 had major birth defects. Four of the babies were born with cleft lips or palates, which is a rate 11 times higher than normal. Additionally, four of the male babies were found to have genital defects, which is a rate 14 times higher than normal.

Illinois Drug Injury Lawyers

Depakote is an anticonvulsant drug commonly prescribed to treat seizure disorders such as epilepsy. This new class action suit marks the third class action filed in Illinois against Abbott Laboratories, the makers of Depakote. Plaintiffs allege that Depakote caused serious birth defects in their children ranging from spina bifida to heart conditions.

(PRWEB) - The Consumer Justice Foundation is committed to keeping the American people up to date concerning the potential harms of defective products and dangerous drugs by providing such resources as http://www.depakotebirthinjury.com. The Consumer Justice Foundation, a free online resource for those who are struggling with legal or personal injury issues in relation to insurance companies and/or large corporations, hereby announces that Depakote class action lawsuits have been filed by plaintiffs in St. Clair County, Illinois against the manufacturer of Depakote, Abbott Laboratories. These Depakote lawsuits seek damages for the classes of plaintiffs that would be used to compensate them for medical expenses incurred and future costs that will be incurred in caring for those who have been harmed as a result of using Depakote.

Texas Drug Injury Lawyers

In March 2011, the U.S. Food and Drug Administration strengthened its warning against the anti-consulant drug, Topamax, because new data suggests an increased risk of birth defects such as cleft palate or cleft lip.

Austin, TX (PRWEB) - O’Hanlon, McCollom & Demerath reports that the U.S. Food and Drug Administration recently strengthened its warning on Topamax because new data suggests an increased risk of birth defects such as cleft palate or cleft lip if used during pregnancy. Oral clefts occur when parts of the lip or palate fail to completely fuse together during gestation. The defect can result in a small, notched lip or in extreme cases, an open groove that extends from the nose to the roof of the mouth. Cleft lip and cleft palate birth defects can cause problems eating and talking, and can also increase the risk of ear infections.